Parabilis Medicines, Inc. ( PBLS) - Key Metrics
PBLS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$1.81 | -$0.13 | -$0.15 |
| 2026Q1 | $0 | -$22.11 | -$24 | -$24.18 |
| 2025Q2 | $0 | -$17.24 | -$15.40 | -$15.41 |
| 2025Q1 | $0 | -$19 | -$16.93 | -$16.96 |
PBLS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.95 |
| 2026Q1 | 0% | -0.14 |
| 2025Q2 | 0% | -13.89 |
| 2025Q1 | 0% | -0.21 |
PBLS
Price: $22.75
52 week price:
Earnings Per Share: -1.88 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.5 billion